相关实验视频
Updated: May 15, 2025

06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
9.4K
用除草剂中毒导致多重结肠穿孔:病例报告
Tesfaye Birhanu Abebe1,2, Daba Iticha Ayana3, Dereje Gebisa Bedada4
1Department of Surgery, School of medicine, collage of health sciences, Salale University, P.O.BOX: 245, Fiche, Ethiopia. tesfu13b21@gmail.com.
International journal of emergency medicine
|April 11, 2025
概括
本案例报告详细介绍了一例罕见的2,4-Dichlorophenoxyacetic酸 (2,4-D) 除草剂中毒后多重结肠穿孔的情况. 迅速的医疗干预和意识对于管理严重的除草剂毒性至关重要.
科学领域:
- 毒理学 毒理学 毒理学
- 胃肠病学 胃肠病学
- 紧急医疗 紧急医疗
背景情况:
- 2,4-二二酸 (2,4-D) 中毒是系统性毒性的重要原因,特别是在农业地区.
- 常见的症状包括胃肠道,肌肉,脏和神经的影响.
- 多重结肠穿孔是2,4-D摄入的一个非常罕见的并发症.
研究的目的:
- 报告一个独特的多重结肠穿孔病例,这是由于2,4-D摄入导致的.
- 强调在除草剂中毒病例中保持警和及时管理的重要性.
- 突出社区意识和安全除草剂使用指南的需要.
主要方法:
- 一名19岁的男性农民在摄入2,4-D溶液后出现了中毒症状.
- 患者因低血压休克,吸气性肺炎和昏迷而接受治疗.
- 摄入后14天,诊断出多重结肠穿孔,导致手术干预 (整体结肠切除术与结肠切除术).
主要成果:
- 患者在2,4-D摄入后的14天内发病了腹膜炎.
- 发现了多个结肠穿孔,并进行了手术治疗.
- 这代表了由于2,4-D中毒造成的多重结肠穿孔的第一个被记录的人类病例.
结论:
- 警和及时管理对于改善因除草剂中毒而导致多次结肠穿孔的患者的治疗结果至关重要.
- 提高社区对除草剂风险的认识至关重要.
- 制定安全使用除草剂的指导方针可以帮助预防这种严重的中毒事件.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
98
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
98
Esophageal Perforation-II: Clinical Manifestations and Management
28
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
28
Esophageal Perforation-I: Introduction
52
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
52
Prevention of Further Absorption of Poison
756
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
756
Anticholinesterase Agents: Poisoning and Treatment
759
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
759
Gastritis III: Clinical Manifestations and Management
102
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
102

